1. P04.24 MTOR signaling in glioma-associated microglia and macrophages. (19th September 2018) Authors: Zeiner, P S; Lorenz, N I; Burger, M; Luger, A L; Harter, P N; Steinbach, J P; Ronellenfitsch, M W Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P04.47 Nrf2 mediates hypoxic tolerance in human glioblastoma cells. (19th September 2018) Authors: Lorenz, N I; Luger, A; Zeiner, P S; Engel, A L; Harter, P N; Steinbach, J P; Ronellenfitsch, M W Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P14.11 Severe treatment-induced myelosuppression is more frequent in female malignant glioma patients and associated with reduced overall survival. (9th September 2021) Authors: Zeiner, P S; Filipski, K; Forster, M; Voss, M; Fokas, E; Herrlinger, U; Harter, P N; Steinbach, J P; Ronellenfitsch, M W Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗